Literature DB >> 3089140

Artifacts in dilution pharmacokinetic models caused by adherent bacteria.

R Haag, P Lexa, I Werkhäuser.   

Abstract

Liquid cultures of a Pseudomonas aeruginosa strain in Mueller-Hinton broth diluted at rates higher than the bacterial growth rate showed the expected decrease in CFU only for 1 to 2 h. Later the CFU started to increase. This phenomenon can be explained by a hypothesis that assumes that the bacteria multiply in two different compartments. From the first compartment, which comprises bacteria homogeneously distributed in the broth, cells are eliminated at a rate that is dependent on the dilution and growth rates. Concomitantly, the second compartment is formed as a nondilutable adherent population on the surface of the culture vessel. Eventually, only cells stemming from that population appeared in the medium and were subsequently diluted. This hypothesis can be described mathematically by a linear combination of two exponential functions. The calculated values fit the experimental data well. Because similar CFU versus time curves were also found with other strains, care should be taken in interpreting results of experiments performed in liquid cultures and evaluated in terms of CFU. One should bear in mind that within a liquid culture an adherent population may exist, which differs in size according to selective influences (dilution, addition of antibiotics, etc.). This may give rise to artificial and unexpected results.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089140      PMCID: PMC284151          DOI: 10.1128/AAC.29.5.765

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  A simple dilution analog computer for simulation of drug distribution processes.

Authors:  E L Rowe; W Morozowich
Journal:  J Pharm Sci       Date:  1969-11       Impact factor: 3.534

2.  Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other beta-lactam antibiotics.

Authors:  M N Gwynn; T L Webb; G N Rolinson
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

3.  New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.

Authors:  T Murakawa; H Sakamoto; T Hirose; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

4.  New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.

Authors:  S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

Review 5.  Cerebrospinal fluid alterations in herpes simplex virus encephalitis.

Authors:  M Koskiniemi; A Vaheri; E Taskinen
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct
  5 in total
  11 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

2.  Optimal control strategies for disinfection of bacterial populations with persister and susceptible dynamics.

Authors:  N G Cogan; Jason Brown; Kyle Darres; Katherine Petty
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

3.  Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.

Authors:  E Löwdin; I Odenholt; S Bengtsson; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

4.  Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.

Authors:  D M Cappelletty; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models.

Authors:  S Keil; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

6.  Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.

Authors:  J W Mouton; J G den Hollander
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

7.  In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli.

Authors:  C A White; R D Toothaker; A L Smith; J T Slattery
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

8.  Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.

Authors:  K J Madaras-Kelly; B E Ostergaard; L B Hovde; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

9.  Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.

Authors:  H Anwar; J L Strap; K Chen; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

10.  Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model.

Authors:  D M Cappelletty; S L Kang; S M Palmer; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.